Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05766423 · ClinicalTrials.gov registry record · NA

Phenotyping Adherence Through Technology-Enabled Reports and Navigation

A NA study of Medication Adherence, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
73
Enrollment target
1
Study location

NCT05766423 is a NA study of Medication Adherence that has completed, run by Northwestern University. The registered enrollment target is 73 participants, below the 1,655-participant average among 52 other Medication Adherence trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05766423, a NA study of Medication Adherence, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
73 participants
Enrollment target
1
Study location

Study Summary

This study is being conducted to adapt and pilot test a technology-enabled, primary care strategy for routinely monitoring medication use and adherence among older adults with multiple chronic conditions and polypharmacy.

Conditions Studied

Interventions

  • BEHAVIORAL The PATTERN Intervention

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 73 participants
Start Date 2024-01-18
Est. Completion 2024-08-15
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT05766423

The ClinicalTrials.gov registry entry for NCT05766423 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,655-participant average among 52 other Medication Adherence trials with a reported enrollment target (96% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Medication Adherence appearing as the primary indexed condition, and to 1 intervention - of which The PATTERN Intervention is the first listed.

NCT05766423 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05766423 about?

NCT05766423 is a clinical study titled "Phenotyping Adherence Through Technology-Enabled Reports and Navigation". This study is being conducted to adapt and pilot test a technology-enabled, primary care strategy for routinely monitoring medication use and adherence among older adults with multiple chronic conditions and polypharmacy.

What is the current status of trial NCT05766423?

This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2024-01-18. Estimated completion is 2024-08-15.

What conditions does trial NCT05766423 study?

This clinical trial studies the following conditions: Medication Adherence.

What interventions are being tested in trial NCT05766423?

The interventions under investigation include: The PATTERN Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05766423?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05766423 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Medication Adherence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.